Go Pro
NASDAQ:FBIOP

Fortress Biotech (FBIOP) Stock Price, News & Analysis

Fortress Biotech logo
$16.80 +0.75 (+4.64%)
Closing price 03:50 PM Eastern
Extended Trading
$16.80 0.00 (-0.03%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Fortress Biotech Stock (NASDAQ:FBIOP)

Advanced

Key Stats

Today's Range
$16.20
▼
$17.25
50-Day Range
$16.06
▼
$19.94
52-Week Range
$6.27
▼
$21.43
Volume
25,189 shs
Average Volume
20,127 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
13.92%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Fortress Biotech, Inc. is a biopharmaceutical company focused on developing and commercializing medicines for serious diseases with significant unmet medical needs. The company uses a subsidiary-based business model in which specialized biotechnology companies advance therapies in areas including oncology, dermatology, rare diseases, infectious diseases and neurology.

Fortress and its subsidiaries develop products across multiple stages, from early research and clinical development to regulatory approval and commercialization. Its portfolio has included treatments for rare and serious conditions, as well as topical and other specialty medicines. The company also works with external partners and uses its development platform to support the creation of additional biotechnology businesses and product candidates.

Founded in 2014, Fortress Biotech is headquartered in the United States and primarily serves patients through the development and commercialization of therapies for domestic and international markets. Its securities include preferred stock listed on the Nasdaq Capital Market under the symbol FBIOP.

AI Generated. May Contain Errors.

Receive FBIOP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fortress Biotech and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

FBIOP Stock News Headlines

Fortress Biotech (NASDAQ:FBIOP) Shares Down 1% - Should You Sell?
Trump goes "all-in" on Grand Canyon energy breakthrough
A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years. While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million. One company controls the entire supply chain behind this discovery.tc pixel
See More Headlines

FBIOP Stock Analysis - Frequently Asked Questions

Fortress Biotech's stock was trading at $9.49 at the start of the year. Since then, FBIOP shares have increased by 77.1% and is now trading at $16.8050.

Shares of FBIOP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
10/02/2026
Next Earnings (Estimated)
11/16/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:FBIOP
CIK
1429260
Fax
N/A
Employees
78
Year Founded
2006

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$68.47 million
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (NASDAQ:FBIOP) was last updated on 10/2/2026 by MarketBeat.com Staff.
From Our Partners